前往化源商城

Bioorganic & Medicinal Chemistry 2007-12-15

Hologram QSAR model for the prediction of human oral bioavailability.

Tiago L Moda, Carlos A Montanari, Adriano D Andricopulo

文献索引:Bioorg. Med. Chem. 15 , 7738-45, (2007)

全文:HTML全文

摘要

A drug intended for use in humans should have an ideal balance of pharmacokinetics and safety, as well as potency and selectivity. Unfavorable pharmacokinetics can negatively affect the clinical development of many otherwise promising drug candidates. A variety of in silico ADME (absorption, distribution, metabolism, and excretion) models are receiving increased attention due to a better appreciation that pharmacokinetic properties should be considered in early phases of the drug discovery process. Human oral bioavailability is an important pharmacokinetic property, which is directly related to the amount of drug available in the systemic circulation to exert pharmacological and therapeutic effects. In the present work, hologram quantitative structure-activity relationships (HQSAR) were performed on a training set of 250 structurally diverse molecules with known human oral bioavailability. The most significant HQSAR model (q(2)=0.70, r(2)=0.93) was obtained using atoms, bond, connection, and chirality as fragment distinction. The predictive ability of the model was evaluated by an external test set containing 52 molecules not included in the training set, and the predicted values were in good agreement with the experimental values. The HQSAR model should be useful for the design of new drug candidates having increased bioavailability as well as in the process of chemical library design, virtual screening, and high-throughput screening.

相关化合物

结构式 名称/CAS号 全部文献
氢氯噻嗪 结构式 氢氯噻嗪
CAS:58-93-5
吡罗昔康 结构式 吡罗昔康
CAS:36322-90-4
炔诺酮 结构式 炔诺酮
CAS:68-22-4
利福平 结构式 利福平
CAS:13292-46-1
R-文拉法辛 结构式 R-文拉法辛
CAS:5543-58-8
对乙酰氨基苯酚 结构式 对乙酰氨基苯酚
CAS:103-90-2
甲基泼尼松龙 结构式 甲基泼尼松龙
CAS:83-43-2
红霉素 结构式 红霉素
CAS:114-07-8
(S)-(+)-布洛芬 结构式 (S)-(+)-布洛芬
CAS:51146-56-6
阿司匹林 结构式 阿司匹林
CAS:50-78-2